8-OH-DPAT, a 5-HT(1a) agonist and ritanserin, a 5-HT(2A/C) antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release

Psychopharmacology

Volumn 131, Issue 1, 1997, Pages 57-63

  Lucas, Guillaume ^a   Bonhomme, Norbert ^b   De Deurwaerdère, Philippe ^a   Le Moal, Michel ^a   Spampinato, Umberto ^a  

^a INSERM   (France)

^b Ist Ric Farmacologiche M N   (Italy)

Author keywords

8 OH DPAT; Catalepsy; Dopamine; Haloperidol; Microdialysis; Ritanserin; Serotonin; Striatum

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HALOPERIDOL; RITANSERIN; SEROTONIN 1A AGONIST; SEROTONIN 1C RECEPTOR; SEROTONIN 2A ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALEPSY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; INTRACEREBRAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; CATALEPSY; DOPAMINE; HALOPERIDOL; MALE; RATS; RATS, SPRAGUE-DAWLEY; RITANSERIN; VISUAL CORTEX;

EID: 0030906167     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050265     Document Type: Article

References (50)

1. Andersson JL, Nomikos GG, Marcus M, Hertel P, Mathé JM, Svensson TH (1995) Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectively in the mesolimbic dopaminergic system. Naunyn-Schmiedeberg's Arch Pharmacol 352:374-385
2. 1A receptor selective ligands, (R)-8- OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons. Naunyn-Schmiedeberg's Arch Pharmacol 347:353-362
3. Balsara JJ, Jadhav JH, Chandorkar AG (1979) Effects of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy. Psychopharmacology 62:67-69
4. Bendotti C, Samanin R (1986) 8-Hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicits feeding in free feeding rats by acting on central serotonin neurons. Eur J Pharmacol 121:147-150
5. Benloucif S, Galloway MP (1991) Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Eur J Pharmacol 200:1-8
6. 2 receptors antagonists can attenuate submaximal haloperidol-induced catalepsy in rats. Schizophr Res 15: 153-154
7. 4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rats. Neuropharmacology 34:269-279
8. Bonvento G, Scatton B, Claustre Y, Rouquier L (1992) Effects of local injection of 8-OH-DPAT into the dorsal or median raphé nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain. Neurosci Lett 132:101-104
9. Brougham LR, Conway PG, Ellis DB (1991) Effect of ritanserin on the interaction of amfonelic acid and neuroleptic-induced striatal dopamine metabolism. Neuropharmacology 30:1137-1140
10. Carter CJ, Pycock CJ (1977) Possible importance of 5-hydroxytryptamine in neuroleptic-induced catalepsy in rats. Br J Pharmacol 60:267P-268P
11. Costall B, Fortune DH, Naylor RJ, Marsden CD, Pycock CJ (1975) Serotonergic involvement with neuroleptic catalepsy. Neuropharmacology 14:859-868
12. De Simoni MG, Dal Toso G, Fodritto F, Sokola A, Algeri S (1987) Modulation of striatal dopamine metabolism by the activity of dorsal raphé serotonergic afferences. Brain Res 411:81-88
13. Devaud LL, Hollingsworth EB, Cooper BR (1992) Alterations in extracellular and tissue levels of biogenic amines in rat brain induced by the serotonin: receptor antagonist, ritanserin. J Neurochem 59:1459-1466
14. Dewey ST, Smith GS, Logan J, Alexoff D, Ding YS, King P, Pappas N, Brodie JD, Ashby CR Jr (1995) Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis. J Neurosci 15:821-829
15. Dray A (1981) Serotonin in the basal ganglia: functions and interactions with other neuronal pathways. J Physiol Paris 77: 393-403
16. 2 receptors in the effects of the classical neuroleptic haloperidol and the atypical neuroleptic clozapine. Eur J Pharmacol 196:103-108
17. Fibiger HC, Miller JJ (1977) An anatomical and electrophysiological investigation of the serotonergic projection from the dorsal raphé nucleus to the substantia nigra in rat. Neuroscience 2:975-987
18. Gonon FG (1988) Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroseience 24:19-28
19. Goodwin GM, De Souza RJ, Green AR, Heal DJ (1987) The pharmacology of the behavioural and hypothermic responses of rats to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Psychopharmacology 91:506-511
20. Hertel P, Nomikos GG, Iurlo M, Svensson TH (1996) Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain. Psychopharmacology 124:74-86
21. Hicks PB (1990) The effect of serotoninergic agents on haloperidol-induced catalepsy. Life Sci 47:1609-1615
22. 1A agonist 8-OH-DPAT stimulates rat motor activity. Eur J Pharmacol 160:303-307
23. 1A receptors can prevent haloperidol-induced catalepsy without influencing the concurrently enhanced dopamine utilisation in the rat brain. Br J Pharmacol 111:11P
24. Hornyckiewicz O (1973) Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA). Br Med Bull 29:172-178
25. Ichikawa J, Kuroki T, Kitchen MT, Johnston HA, Dai J, Meltzer HY (1995) R(+)-8-OH-DPAT blocked atypical antipsychotic (AP)-induced dopamine (DA) release in rat striatum (STR) and nucleus accumbens (NAC). 25th Ann Meet Soc Neurosci (Abstr) 21:152.5
26. Imperato A, Di Chiara G (1985) Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis. J Neurosci 5:297-306
27. Invernizzi RW, Cervo L, Samanin R (1988) 8-Hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin IA receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis. Neuropharmacology 27: 515-518
28. Kapur S, Remington G (1996) Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 153:466-476
29. Kelland MD, Freeman AS, Chiodo LA (1990) Serotonergic afferent regulation of the basal physiology and pharmacological responsiveness of nigrostriatal dopamine neurons. J Pharmacol Exp Ther 253:803-811
30. 2 antagonist. Mol Pharmacol 27:600-611
31. 2 receptors. Psychopharmacology 112:S40-S54
32. Meltzer HY, Nash JF (1991) Effects of antipsychotic drugs on serotonin receptors. Pharmacol Rev 43:587-604
33. 1 recognition sites. Eur J Pharmacol 90:151-153
34. 2 antagonists and minaprine block the 5-HT-induced inhibition of dopamine release from rat brain striatal slices. Eur J Pharmacol 153:89-95
35. Neal-Beliveau BS, Joyce JN, Lucki I (1993) Serotonergic involvement in haloperidol-induced catalepsy. J Pharmacol Exp Ther 265:207-217
36. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, New York
37. Perry KW, Fuller RW (1989) Determination of brain concentrations of 8-hydroxy-2-(di-n-propylamino)tetralin by liquid chromatography with electrochemical detection. Biochem Pharmacol 38:3169-3173
38. Protais P, Chagraoui A, Arbaoui J, Mocaër E (1994) Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents. Eur J Pharmacol 271:167-177
39. 2 antagonists modulates the effects of D-2 dopamine receptor blockade. J Pharmacol Exp Ther 253:1162-1170
40. Sanberg PR (1980) Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors. Nature 284:472-473
41. Santiago M, Westerink BHC (1990) Characterization of the in vivo release of dopamine as recorded by different types of intracerebral microdialysis probes. Naunyn-Schmiedeberg's Arch Pharmacol 342:407-414
42. 2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine. Eur J Pharmacol 223:65-74
43. 1A agonists. J Pharmacol Exp Ther 273:101-112
44. Soubrié P, Reisine TD, Glowinski J (1984) Functional aspects of serotonin transmission in the basal ganglia: a review and an in vivo approach using the push-pull cannula technique. Neuroscience 13:605-625
45. Spoont MR (1992) Modulatory role of serotonin in neural information processing: implications for human psychopathology. Psychol Bull 112:330-350
46. Tanda G, Carboni E, Frau R, Di Chiara G (1994) Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? Psychopharmacology 115:285-288
47. 1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino) tetralin in the rat. Eur J Pharmacol 106:271-282
48. 2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition. Psychopharmacology 98: 45-50
49. Waldmeier PC, Delini-Stula AA (1979) Serotonin-dopamine interactions in the nigro-striatal system. Eur J Pharmacol 55: 363-373
50. Zetterström T, Sharp T, Ungerstedt U (1984) Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis. Eur J Pharmacol 106: 27-37